| Physical activity and estrogen treatment reduce visceral body fat and serum levels of leptin in an additive manner in a diet induced animal model of obesity. | |
| | |
MedLine Citation:
|
PMID: 20298783 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Estrogen replacement and physical activity have been demonstrated to reduce the risk to develop a metabolic syndrome in postmenopausal women. In this study we investigate the combined effects of endurance training and estrogen substitution in a rat animal model of diet induced obesity. Effects on lipid and glucose metabolism were evaluated. Ovariectomized (OVX) or sham-operated (SHAM) female Wistar rats were fed with a high fat diet (HF) for 9 weeks. After 3 weeks of overnutrition the OVX rats either remained sedentary, performed treadmill training, received 17β-Estradiol (E(2)), or combined treatment. The OVX rats had a greater increase in body weight and serum levels of cholesterol, triglyceride and low-density lipoprotein cholesterol (LDL). These parameters could be reduced by E(2) and more effectively E(2) in combination with exercise. Also the increase of visceral body fat and leptin could be improved by E(2) and exercise. This combination showed synergistic effects. Serum levels of insulin could be reduced by exercise training, E(2) substitution revealed no significant changes. Our results indicate that ovariectomy increases the susceptibility to develop obesity. In addition they show that the combination of hormone replacement therapy (HRT) and physical activity may influence parameters related to lipid metabolism positively in an additive manner. The results of this study provide evidence that the combination of HRT with physical activity could be a very effective strategy to prevent the development of a metabolic syndrome induced by overnutrition. |
| | |
Authors:
|
Nora Zoth; Carmen Weigt; Ute Laudenbach-Leschowski; Patrick Diel |
Related Documents
:
|
1415883 - Exercise performance of collegiate rodeo athletes. 2303663 - Nutrition and the precontest preparations of a male bodybuilder. 1298143 - Efficacy, safety and tolerability of lovastatin and bezafibrate retard in patients with... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-03-16 |
Journal Detail:
|
Title: The Journal of steroid biochemistry and molecular biology Volume: 122 ISSN: 1879-1220 ISO Abbreviation: J. Steroid Biochem. Mol. Biol. Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-13 Completed Date: 2010-10-15 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9015483 Medline TA: J Steroid Biochem Mol Biol Country: England |
Other Details:
|
Languages: eng Pagination: 100-5 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Department of Cellular and Molecular Sports Medicine, Institute of Cardiovascular Research and Sports Medicine, German Sports University, Cologne, Germany. n.zoth@dshs-koeln.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Body Weight Cholesterol / blood Estradiol / pharmacology* Female Insulin / blood Intra-Abdominal Fat / metabolism Leptin / blood* Obesity / metabolism* Organ Size Ovariectomy Physical Conditioning, Animal / physiology* Random Allocation Rats Rats, Wistar Triglycerides / blood |
| Chemical | |
Reg. No./Substance:
|
0/Leptin; 0/Triglycerides; 11061-68-0/Insulin; 50-28-2/Estradiol; 57-88-5/Cholesterol |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sun exposure questionnaire predicts circulating 25-hydroxyvitamin D concentrations in Caucasian hosp...
Next Document: Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism.